Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
Stress in Multiple Sclerosis: Review of New Developments and Future Directions.
A case of IgM paraproteinemic neuropathy associated with anti-sulfated glucuronic paragloboside (SGPG) IgG antibody without anti-myelin-associated glycoprotein (MAG) activity.
Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study.
Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology.
Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study.
Neurofascin 186 specific autoantibodies induce axonal injury and exacerbate disease severity in experimental autoimmune encephalomyelitis.
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton.
Evidence That Erythropoietin Modulates Neuroinflammation through Differential Action on Neurons, Astrocytes, and Microglia.
Co-occurrence of multiple sclerosis and Thomsen's myotonia: a report of two cases.
A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol.
Bladder dysfunction and quality of life for people with multiple sclerosis.
Multiple sclerosis drugs: how much bang for the buck?
Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Impaired sleep-associated modulation of post-exercise corticomotor depression in multiple sclerosis.
[Criteria of ineffectiveness of treatment with first-line therapy: how to use MRI results in decision making?]
Feasibility of Cell Therapy in Multiple Sclerosis: A Systematic Review of 83 Studies.
Low prevalence of human herpesvirus-6 and varicella zoster virus in blood of multiple sclerosis patients, irrespective of inflammatory status or disease progression.
Optic and auditory pathway dysfunction in demyelinating neuropathies.
Month of birth is not a definite risk factor for multiple sclerosis.
Neuromyelitis optica spectrum disorders.
How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.
Processes of plasma protein N-homocysteinylation in multiple sclerosis.
Natural history of multiple sclerosis from the Indian perspective: Experience from a tertiary care hospital.
The neuroimaging of Leigh syndrome: case series and review of the literature.

Pages